250 related articles for article (PubMed ID: 28264037)
1. Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity.
Gott C; Gates T; Dermody N; Brew BJ; Cysique LA
PLoS One; 2017; 12(3):e0171887. PubMed ID: 28264037
[TBL] [Abstract][Full Text] [Related]
2. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China.
Cysique LA; Letendre SL; Ake C; Jin H; Franklin DR; Gupta S; Shi C; Yu X; Wu Z; Abramson IS; Grant I; Heaton RK;
AIDS; 2010 Apr; 24(7):983-90. PubMed ID: 20299964
[TBL] [Abstract][Full Text] [Related]
3. Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not.
Aung HL; Siefried KJ; Gates TM; Brew BJ; Mao L; Carr A; Cysique LA
EClinicalMedicine; 2023 Feb; 56():101792. PubMed ID: 36618901
[TBL] [Abstract][Full Text] [Related]
4. Pre-frailty predicts cognitive decline at 2-year follow-up in persons living with HIV.
Paolillo EW; Sun-Suslow N; Pasipanodya EC; Morgan EE; Ellis RJ; Jeste DV; Moore DJ
J Neurovirol; 2020 Apr; 26(2):168-180. PubMed ID: 31858484
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study.
Janssen MAM; Koopmans PP; Kessels RPC
AIDS Behav; 2017 Jun; 21(6):1728-1734. PubMed ID: 27752871
[TBL] [Abstract][Full Text] [Related]
6. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.
Dufouil C; Richert L; Thiébaut R; Bruyand M; Amieva H; Dauchy FA; Dartigues JF; Neau D; Morlat P; Dehail P; Dabis F; Bonnet F; Chêne G;
Neurology; 2015 Sep; 85(12):1065-73. PubMed ID: 26156515
[TBL] [Abstract][Full Text] [Related]
8. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia.
Mukherjee T; Sakthivel R; Fong HY; McStea M; Chong ML; Omar SF; Chin AV; Kamaruzzaman S; Kamarulzaman A; Rajasuriar R; Cysique LA
AIDS Behav; 2018 Oct; 22(10):3226-3233. PubMed ID: 29508103
[TBL] [Abstract][Full Text] [Related]
9. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
[TBL] [Abstract][Full Text] [Related]
10. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
11. Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis.
Brouillette MJ; Yuen T; Fellows LK; Cysique LA; Heaton RK; Mayo NE
PLoS One; 2016; 11(5):e0155766. PubMed ID: 27191850
[TBL] [Abstract][Full Text] [Related]
12. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.
Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ
AIDS; 2016 Feb; 30(4):591-600. PubMed ID: 26825032
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.
Anderson AE; Jones JD; Thaler NS; Kuhn TP; Singer EJ; Hinkin CH
Neuropsychology; 2018 Nov; 32(8):966-972. PubMed ID: 30211610
[TBL] [Abstract][Full Text] [Related]
14. Properties of a brief assessment tool for longitudinal measurement of cognition in people living with HIV.
Brouillette MJ; Fellows LK; Finch L; Thomas R; Mayo NE
PLoS One; 2019; 14(3):e0213908. PubMed ID: 30908501
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
[TBL] [Abstract][Full Text] [Related]
16. Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.
Mukerji SS; Locascio JJ; Misra V; Lorenz DR; Holman A; Dutta A; Penugonda S; Wolinsky SM; Gabuzda D
Clin Infect Dis; 2016 Oct; 63(8):1130-1139. PubMed ID: 27448678
[TBL] [Abstract][Full Text] [Related]
17. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
[TBL] [Abstract][Full Text] [Related]
18. The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M
J Neurovirol; 2016 Feb; 22(1):56-65. PubMed ID: 26304840
[TBL] [Abstract][Full Text] [Related]
19. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
[TBL] [Abstract][Full Text] [Related]
20. Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.
Kisakye A; Saylor D; Sacktor N; Nakigozi G; Nakasujja N; Robertson K; Anok A; Wawer M; Gray R
AIDS Care; 2019 Jul; 31(7):836-839. PubMed ID: 30554522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
